Gilda’s Club Chicago, cancer organizations launch metastatic breast cancer awareness campaign

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

GILDA’S CLUB CHICAGO and other organizations across the country launched the It’s About Time campaign, an initiative to raise awareness of metastatic breast cancer.

“It is our hope that the It’s About Time campaign will help inform the public about metastatic breast cancer and metastatic disease in general, while giving those diagnosed, their families and friends a greater voice. ” said Laura-Jane Hyde, CEO, Gilda’s Club Chicago said in a statement.

It’s About Time encourages metastatic breast cancer patients, their families, caretakers and advocacy organizations to engage in a national conversation over the next six weeks about metastatic breast cancer facts, what time means to them, opportunities for increased advocacy and research supporting metastatic breast cancer, and, most importantly, to create a platform for those battling metastatic breast cancer to share their stories.

Table of Contents

YOU MAY BE INTERESTED IN

The rapid adoption of glucagon-like peptide-1 receptor agonists (GLP-1RAs), particularly for weight management, represents one of the most significant shifts in metabolic medicine in decades. With millions of people now using medications such as semaglutide and tirzepatide, we are witnessing a fundamental alteration in patient physiology that extends far beyond glucose control and weight loss. As these drugs approach 10% population penetrance in some demographics, the oncology community faces an urgent question: How will this metabolic transformation reshape cancer care?

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login